By: IPP Bureau
Last updated : August 11, 2026 6:32 pm
The new center is expected to become operational in 2027 and will be part of Amgen’s global network of seven research laboratories
Amgen has announced plans to establish a new Science and Innovation Center at Genome Valley in Hyderabad, expanding its global research and development capabilities and strengthening India’s role in the company’s worldwide R&D network.
The new center is expected to become operational in 2027 and will be part of Amgen’s global network of seven research laboratories.
The facility will focus on integrating advanced scientific capabilities with data and digital innovation to accelerate the discovery and development of innovative medicines. It will bring together scientists and technologists working across discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine, while collaborating closely with Amgen’s research sites globally.
“The new center in Genome Valley expands the way we integrate experimental science with data and technology across our global research capabilities and complements our strong U.S.-based Research and Development footprint,” said Jay Bradner, M.D., Executive Vice President of Research and Development, Artificial Intelligence and Data at Amgen. “By connecting these capabilities, we can learn faster and translate those insights into innovative medicines for patients.”
D. Sridhar Babu, Minister for Information Technology, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Government of Telangana said, “Amgen’s decision to establish its Science and Innovation Center in Genome Valley reflects Hyderabad’s growing role as a global hub for high-value research, bringing together scientific talent, technology and industry at scale. Our ambition is to make Hyderabad a place where the next generation of medicines and therapies can be discovered, developed and taken to the world,.”
Som Chattopadhyay, Senior Vice President of Global Business Solutions and National Executive at Amgen, said the new center would further reinforce the company’s commitment to scientific excellence and India’s role in its global R&D network.
“This new center reflects Amgen’s commitment to advancing scientific excellence, and India will be an important part of our global R&D network,” said Som Chattopadhyay. “By expanding Amgen’s global research capabilities through its Hyderabad site, we are enabling deep scientific collaboration and look forward to participating in the local innovation ecosystem.”